Novo Nordisk Production Sas is a finished-dose manufacturer based in France. It appears in 19 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), UZPHARM (UZ) and NCELS (KZ). Its GMP standing is certified by ANSM (FR), EMA and ANVISA (Brazil), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 5 April 2023 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Chartres, United Arab Emirates | Not on file |
| CHARTRES, France | Not on file |
| Chartres, France | Not on file |
| Ireland, Ireland | 3002806873 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 7 | None |
| UZPHARM (UZ) | 4 | None |
| NCELS (KZ) | 3 | 1 |
| INVIMA (CO) | 2 | None |
| DIGEMAPS (DO) | 2 | None |
| BOMRA (BW) | 1 | None |
| ANSM (FR) | None | 5 |
| EMA | None | 3 |
| ANVISA (Brazil) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $256.2M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Novo Nordisk Production Sas comes back tiered against every other supplier able to file there.
Start for free